American Herbal Products Association (AHPA) > News

AHPA Provides Perspective on Emergency Room Visits Purportedly Associated with Supplements

When placed into context, study demonstrates relative safety of supplements

Article published in New England Journal of Medicine

overstates emergency room (ER) visits associated with dietary supplements. Study also shows supplements are relatively safe compared to other product categories.

AHPA urges USP to use more precise terminology in proposed general chapter

August 2015: AHPA Update

AHPA expresses concern that USP's proposal confuses unlawful misbranded drugs with legal dietary supplements

AHPA Revises Guidance on Prop 65 Warnings for Pulegone

Does Naturally Occurring Pulegone Represent 'Exposure' Under CA Prop 65?

AHPA has updated guidance to help members understand and comply with California Proposition 65 requirements when selling products that contain pulegone, a ketonic monoterpene that is a naturally present constituent in various plant species, including mints.

Limitations of DNA testing for botanical identification

April 14, 2015: DNA analysis can generate false negative results due to the normal and expected lack of DNA in some processed herbal ingredients

The statement provides the view of the American Herbal Products Association of the current state of the science of the use of DNA barcoding as a technique for authenticating the identity of herbal materials for this purpose and is intended to explain any misunderstandings that may arise out of the March 30 agreement as to the currently limited applicability of this analytical technique.

AHPA Policy prohibits the sale of bulk caffeine

Recent reports associate serious injury and death with use of pure caffeine purchased by consumers in bulk packaging

The American Herbal Products Association (AHPA) Board of Trustees on March 4 established a trade requirement that prohibits sale by AHPA members of pure caffeine in bulk form at retail (to consumers).

Whitepaper on DNA barcode testing reveals how misapplication of science led to baseless results

The Capabilities and Limitations of DNA Barcode Testing

A comprehensive analysis of DNA barcode testing on botanical dietary supplements has called conclusions reached by the New York Attorney General’s (NY AG) office in an investigation of four major retailers of botanical supplements, a “…misuse of the technologies” that led to a “…misinterpretation of test results.”

AHPA responds to dozens of media outlets' coverage of New York Attorney General's inadequate testing of herbal supplements

AHPA has responded to more than 20 media outlets' coverage of the New York State Attorney General's supplement investigation to stress that the allegations are based on inadequate and unproven testing of herbal supplement products. The test results are at the core of the Attorney General's misinformed allegations that several major retailers are selling adulterated and/or mislabeled herbal dietary supplements.

AHPA-ERB Foundation Forms The American Ginseng Advisory Panel

American Herbal Products Association (AHPA) Foundation for Education and Research on Botanicals (AHPA-ERB Foundation) formed the American Ginseng Advisory Panel to provide expertise on the development and maintenance of collecting plant material that will preserve the genetic diversity of wild American Ginseng

The American Herbal Products Association (AHPA) Foundation for Education and Research on Botanicals (AHPA-ERB Foundation) formed the American Ginseng Advisory Panel to provide expertise on the development and maintenance of collecting plant material that will preserve the genetic diversity of wild American Ginseng (Panax quinquefolius).

Cannabis oversight recommendations for regulators

September 10, 2014: Oversight framework promotes best practices for cannabis production and distribution from seed to consumption

The American Herbal Products Association (AHPA) has published recommendations for regulators to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species.

Federal judge approves consent decree with New York dietary supplement maker (FDA)

A federal judge in New York has signed a consent decree for permanent injunction between the United States and Mira Health Products Ltd., a dietary supplement manufacturer located in Farmingdale, New York, and Michael S. Ragno and Michael S. Ragno, Jr.

Alerts

Subscribe>>

AHPA Alerts